KALA BIO, Inc. (KALA)
(Delayed Data from NSDQ)
$19.14 USD
+2.24 (13.22%)
Updated Sep 24, 2025 04:00 PM ET
After-Market: $19.10 -0.04 (-0.18%) 5:22 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KALA 19.14 +2.24(13.22%)
Will KALA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KALA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KALA
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade
Zacks.com featured highlights include KALA, Graham, Arq and Hawkins
KALA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analyst Coverage Sparks Interest in These 4 Stocks Amid Volatility
KALA BIO (KALA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
KALA BIO (KALA) Moves to Strong Buy: Rationale Behind the Upgrade
Other News for KALA
KALA forms MACD Bearish Signal Line Cross on September 24
The technical outlook for KALA is unchanged after it falls 5.5% on September 22
New 52 Week Closing High appears for KALA after 11.95% move
Slingshot Bullish appears for KALA after 0.37% move
Slingshot Bullish appears for KALA after 4.64% move